The short version of preclinical models fits in a sentence. The long version — which is the one that helps — is below.
Reviewed 2025-09-20. Anything still debated is marked as such rather than presented as settled.
Cardarine is explicitly prohibited by the World Anti-Doping Agency under the class of PPARδ agonists. Its presence in urine or blood samples can be detected using mass spectrometry-based methods, often liquid chromatography-tandem mass spectrometry. Athletes who test positive may face sanctions, including bans from competition. The compound is also regulated as a prescription-only or unapproved drug in many countries. Enforcement varies by jurisdiction, and some regions treat it as a controlled substance. Online sales may occur despite these restrictions, creating quality and legal risks.
Laboratory detection of cardarine typically involves sample preparation followed by chromatographic separation and mass spectrometric identification. Urine is the most common matrix for anti-doping tests, though blood and hair have also been explored. Methods can target the parent compound or its metabolites, depending on the expected window of detection. Reference standards are required for accurate quantification. Matrix effects and dilution can influence results, so laboratories use internal standards and validation protocols. The exact detection window varies with dose, route, and individual metabolism.
A common misconception is that cardarine has been proven safe for human use. In reality, human clinical data are limited, and long-term animal studies have raised concerns about cancer. Another misconception is that it is a supplement or vitamin-like compound. It is a synthetic research chemical with no approved medical indication. Scientific discussion often focuses on its mechanism and detection rather than therapeutic use. Regulatory and anti-doping literature treats it primarily as a prohibited substance.
Cardarine is a common name for GW501516, a synthetic compound first described in the 1990s as a selective agonist of the peroxisome proliferator-activated receptor delta. It was studied in preclinical models for metabolic and cardiovascular conditions, but it has not been approved as a medicine in the United States, Europe, or other major jurisdictions. Retail products labeled as cardarine are generally research chemicals or supplements, not pharmaceutical formulations. Because human safety and efficacy data remain limited, regulatory agencies treat it as an unapproved substance rather than a therapeutic product.
Sporting authorities added GW501516 to prohibited lists after it appeared in athlete samples and online markets. The World Anti-Doping Agency classifies it as a hormone and metabolic modulator, and its use can lead to an anti-doping rule violation. Some early laboratory work suggested effects on fatty acid oxidation and endurance-related metabolism in animals, but those findings do not establish safe or effective use in people. Reports of adverse events in humans are scarce and often anecdotal, which complicates risk assessment.
| Property | Value | Notes |
|---|---|---|
| Regulatory status | Prohibited in sport | Listed by WADA as a PPARδ agonist. |
| Typical detection matrix | Urine | Most common sample for anti-doping analysis. |
| Common analytical method | LC-MS/MS | Liquid chromatography-tandem mass spectrometry. |
| Common synonyms | GW501516, GSK-516, endurobol | Names found in research and fitness contexts. |
| Typical detection window | Variable | Depends on dose, route, and individual metabolism. |
Regulatory treatment varies, but cardarine is not approved as a medicine. Sports authorities list GW501516 as a prohibited substance, and it is banned at all times under the World Anti-Doping Agency code. Many countries restrict sales for human consumption, while online vendors market it as a research chemical. Such products may lack purity data, and their actual contents can differ from the label. Purchasing or possessing cardarine may carry legal consequences depending on jurisdiction. The compound is not a dietary supplement ingredient in regulated markets.
Clinical development stopped after rodent studies showed tumors at multiple sites. Whether those findings predict human cancer risk remains an open question, but they led sponsors to discontinue programs. Human safety data are limited to small, short-term studies that were not designed to assess cancer risk. Reported effects in those studies included changes in blood lipids, but the evidence is insufficient for medical use. Long-term consequences of nonmedical use are not well characterized. Questions about dose, duration, and individual susceptibility remain unresolved.
Safety discussions about cardarine frequently cite rodent carcinogenicity findings reported in the 2000s. In those studies, treated animals developed tumors at multiple sites, leading sponsors to discontinue clinical development. The relevance of these findings to humans has not been resolved, but they are a major reason the compound is not approved. Current literature emphasizes uncertainty about long-term effects and the risks of unregulated use. Regulators and health agencies have not established a safe human exposure level.
Cardarine is a synthetic compound also known as GW501516, GW-501516, and sometimes endurobol. It was developed as a selective agonist of peroxisome proliferator-activated receptor delta, a nuclear receptor involved in fatty acid oxidation and energy metabolism. The compound was studied in preclinical models for metabolic and cardiovascular conditions, but it did not become a marketed human medicine. In regulatory and anti-doping contexts, it is treated as a prohibited substance rather than a licensed medicine.
The pharmacological interest in cardarine centers on PPARδ activation and its downstream effects on lipid handling and mitochondrial function. In animal studies, PPARδ agonists have been associated with changes in exercise endurance and fatty acid utilization, though results vary by model and protocol. Human data remain sparse, and the absence of large controlled trials limits conclusions about efficacy. Researchers often describe the compound as a tool for probing PPARδ biology rather than a proven therapeutic agent.
In the fitness and bodybuilding literature, cardarine is frequently discussed as an endurance agent or fat-loss compound, although such claims are not supported by robust clinical evidence. Online descriptions often mix animal data, user anecdotes, and marketing language. Researchers who study PPARδ agonists distinguish between receptor activation in controlled experiments and unsupervised use of unverified products. The latter introduces unknown purity, dose, and interactions, making reported experiences difficult to interpret scientifically.
GW501516 acts as an agonist at peroxisome proliferator-activated receptor delta, a nuclear receptor involved in transcription of genes related to lipid handling and energy use. Activation of PPARδ can shift skeletal muscle toward greater fatty acid oxidation in animal models, which is one reason it drew interest for metabolic disease and exercise research. The exact downstream effects depend on tissue, species, dose, and duration. Human data are sparse, so many proposed benefits remain hypotheses rather than established clinical outcomes.
On average, the temperature of the ocean surface in the tropical East Pacific is roughly 8–10 °C (14–18 °F) cooler than in the tropical West Pacific. The sea surface temperature (SST) of the West Pacific northeast of Australia averages around 28–30 °C (82–86 °F). SSTs in the East Pacific off the western coast of South America are closer to 20 °C (68 °F). Strong trade winds near the equator drive water away from the East Pacific and into the West Pacific. This water is slowly warmed by the Sun as it moves west along the equator, the wind stress acting on the ocean surface being balanced by a sea surface slope. One result of this is that sea levels near Indonesia are typically around 0.5 m (1.5 ft) higher than that near Peru. The warm surface waters collect in the western Pacific, with the result that the thermocline, the transitional zone between the warmer waters near the ocean surface and the cooler waters of the deep ocean, lies much deeper in the western Pacific, where it has an average depth of around 140 m (450 ft) compared to around 30 m (90 ft) in the East Pacific. At depth, the sloping surface thermocline helps reduce the east–west pressure difference due to the sea level slope, but below the thermocline, the pressure difference is still enough to drive the eastward flowing cold equatorial undercurrent. The cooler deep ocean water replaces the outgoing surface waters in the East Pacific, rising to the ocean surface in a process called upwelling.
== Biography == Minh Le was born in Vietnam. In 1979, he and his parents left Vietnam on a boat and immigrated to Canada as refugees. Le attended Simon Fraser University from 1996 to 2001, graduating in 2001 with a Bachelor of Applied Science degree in Computing Science. His curriculum and electives were "focused mainly on computer graphics courses covering subjects such as compression algorithms, 3D animation techniques, image recognition." Le picked up id Software's Quake in 1996 and began playing with its software development kit, and after about a year he completed his first mod, Navy SEALs, Counter-Strike's spiritual predecessor. While he was working on the Action Quake 2 mod, he came up with the idea for Counter-Strike and became friends with Action Quake 2's webmaster Jess Cliffe and Marcelo Dilay. Le began work on Counter-Strike as a mod for Half-Life while he was in the middle of his fourth year at Simon Fraser University (he later graduated with a degree in computer science). He spent about 20 hours a week on making the mod, expending more effort on it than he did on his schoolwork, and released the first beta version in June 1999. The "Counter-Strike Team" quickly produced several more beta releases in the following months as the game's popularity skyrocketed. By the fourth beta version, Valve, the developer who created Half-Life, began assisting in the development of Counter-Strike. In 2000, Valve acquired the rights to Counter-Strike and hired Le and Cliffe to work at its headquarters Bellevue, Washington.
ECL cells synthesize and secrete histamine. These cells are stimulated by the hormones gastrin (not depicted in the adjacent diagram) and pituitary adenylyl cyclase-activating peptide. G cells are stimulated by vagal stimulation through the neurotransmitter gastrin-releasing peptide; this causes the G cells to secrete gastrin, which in turn stimulates ECL cells to release histamine. Note that this circuit is not activated by acetylcholine (ACh), which is of particular importance because the administration of atropine will not block the vagal stimulation of the G cells, as ACh is not the neurotransmitter for these cells. However, ECL cells are activated directly by ACh on M1 receptors from direct vagal innervation leading to histamine release. This pathway will be inhibited by atropine. Gastrin is transferred from a specific type of G cell in the gastric epithelium to the ECL cells by blood. Histamine and gastrin act synergistically as the most important stimulators of hydrochloric acid secretion from parietal cells and stimulators of secretion of pepsinogen from chief cells. The most important inhibitor of the ECL cell is somatostatin from D cells. Enterochromaffin-like cells also produce pancreastatin and probably other peptide hormones and growth factors.
Sources: en.wikipedia.org
Because of the long-term effects of inflation, notably the significant increase of movie theater ticket prices, the list unadjusted for inflation gives far more weight to later films. The unadjusted list, while commonly found in the press, is therefore largely meaningless for comparing films widely separated in time, as many films from earlier eras will never appear on a modern unadjusted list, despite achieving higher commercial success when adjusted for price increases. To compensate for the devaluation of the currency, some charts make adjustments for inflation, but not even this practice fully addresses the issue, since ticket prices and inflation do not necessarily parallel one another. For example, in 1970, tickets cost $1.55 or about $6.68 in inflation-adjusted 2004 dollars; by 1980, prices had risen to about $2.69, a drop to $5.50 in inflation-adjusted 2004 dollars. Ticket prices have also risen at different rates of inflation around the world, further complicating the process of adjusting worldwide grosses. Another complication is release in multiple formats for which different ticket prices are charged. One notable example of this phenomenon is Avatar, which was also released in 3D and IMAX: almost two-thirds of tickets for that film were for 3D showings with an average price of $10, and about one-sixth were for IMAX showings with an average price over $14.50, compared to a 2010 average price of $7.61 for 2D films.
The Journal of the American Society for Mass Spectrometry is a monthly peer-reviewed scientific journal published by ACS Publications since 2020. From 2011 to 2019 it was published by Springer Science+Business Media and prior to that by Elsevier. It is the official publication of the American Society for Mass Spectrometry and freely available to members. The journal covers all aspects of mass spectrometry. Until 2015, Michael L. Gross (Washington University in St. Louis) was the founding editor-in-chief; he was succeeded by Joseph A. Loo (University of California, Los Angeles). The journal is abstracted and indexed in MEDLINE.
=== 1992–1993: Dirt === In March 1992, the band returned to the studio. With new songs written primarily on the road, the material has an overall darker feel than Facelift, with six of the album's thirteen songs dealing with the subject of addiction. "We did a lot of soul searching on this album. There's a lot of intense feelings." Cantrell said, "We deal with our daily demons through music. All of the poison that builds up during the day we cleanse when we play." On September 29, 1992, Alice in Chains released its second album, Dirt. The album peaked at number six on the Billboard 200 and since its release has been certified 5× platinum by the RIAA, making Dirt the band's highest selling album to date. The album was a critical success, with Huey praising the album as a "major artistic statement, and the closest they ever came to recording a flat-out masterpiece." Chris Gill of Guitar World called Dirt "huge and foreboding, yet eerie and intimate", and "sublimely dark and brutally honest."
=== Linde and CCMP Capital (2006-2014) === Linde AG purchased BOC in 2006 for €12.4 billion, selling Edwards to CCMP Capital and its Asian fund in 2007 for US$901 million. Edwards was renamed Edwards Group Ltd, and then Edwards Group plc. A new, Cayman Island-based holding company called Edwards Group Ltd was listed on NASDAQ in 2012 via ADS under the ticker symbol EVAC, with a US$100 million IPO. It was delisted in 2014 when Atlas Copco purchased the operating subsidiary Edwards Ltd for £1 billion.
Sources: en.wikipedia.org
Yes, WADA prohibits cardarine as a PPARδ agonist. It appears on the prohibited list and can be detected in urine or blood. Athletes using it risk sanctions.
Detection usually uses liquid chromatography-tandem mass spectrometry after sample cleanup. Laboratories look for the parent compound or metabolites. The method requires validated reference standards and controls.
Legality varies by country. In many places it is an unapproved drug and cannot be legally sold for human consumption. Purchasing from online vendors carries legal and quality risks.
No. Major drug regulators have not approved GW501516 for treating any medical condition. Products sold as cardarine are typically unapproved research chemicals or supplements, so their contents and safety are not assured.